Retraction: A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation (Cancer Research (2009) 69 (4277-4285) DOI: 10.1158/0008-5472.CAN-08-3669);A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation

Cancer Research

Volumn 69, Issue 10, 2009, Pages 4277-4285

  Datta, Jharna ^a   Ghoshal, Kalpana ^a,d   Denny, William A ^b   Gamage, Swarna A ^b   Brooke, Darby G ^b   Phiasivongsa, Pasit ^c   Redkar, Sanjeev ^c   Jacob, Samson T ^a,d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c SuperGen Inc ^*  (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; N [4 (2 AMINO 6 METHYLPYRIMIDIN 4 YLAMINO)PHENYL] 4 (QUINOLIN 4 YLAMINO)BENZAMIDE; PROTEASOME; PROTEIN MLH1; PROTEIN P16; QUINOLINE DERIVATIVE; S ADENOSYLMETHIONINE; SGI 1027; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; TUMOR SUPPRESSOR GENE;

EID: 66249127951     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-23-2366     Document Type: Erratum

References (49)

1. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008;9:465-476
2. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6:107-116
3. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-153 (Pubitemid 38198742)
4. Lopez-Serra L, Esteller M. Proteins that bind methylated DNA and human cancer: reading the wrong words. Br J Cancer 2008;98:1881-1885
5. Spada F, Haemmer A, Kuch D, et al. DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells. J Cell Biol 2007;176:565-571 (Pubitemid 46333972)
6. Hermann A, Goyal R, Jeltsch A. The Dnmt1 DNA-(cytosine-C5)- methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J Biol Chem 2004;279:48350-48359 (Pubitemid 39540991)
7. Ghoshal K, Bai S. DNA methyltransferases as targets for cancer therapy. Drugs Today (Barc) 2007;43:395-422. (Pubitemid 47234771)
8. Oki Y, Aoki E, Issa JP. Decitabine-bedside to bench. Crit Rev Oncol Hematol 2007;61:140-152 (Pubitemid 46073782)
9. Castellano S, Kuck D, Sala M, et al. Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1. J Med Chem 2008;51:2321-2325
10. Korkmaz A, Reiter RJ. Epigenetic regulation: a new research area for melatonin? J Pineal Res 2008;44:41-44
11. Byun HM, Choi SH, Laird PW, et al. 2′-Deoxy-N4-2-(4-nitrophenyl) ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1. Cancer Lett 2008;266:238-248
12. Yoo CB, Jeong S, Egger G, et al. Delivery of 5-aza-2′-deoxycytidine to cells using oligodeoxynucleotides. Cancer Res 2007;67:6400-6408 (Pubitemid 47037524)
13. Reich NO, Mashhoon N. Inhibition of EcoRI DNA methylase with cofactor analogs. J Biol Chem 1990;265:8966-8970 (Pubitemid 20167422)
14. Datta J, Majumder S, Bai S, et al. Physical and functional interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in mouse lymphosarcoma cells. Cancer Res 2005;65:10891-10900 (Pubitemid 41713357)
15. Brueckner B, Boy RG, Siedlecki P, et al. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res 2005;65:6305-6311 (Pubitemid 40994416)
16. Ghoshal K, Datta J, Majumder S, et al. 5-Azadeoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol 2005;25:4727-4741 (Pubitemid 40705775)
17. Bai S, Ghoshal K, Jacob ST. Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells. J Biol Chem 2006;281:13604-13611 (Pubitemid 43855275)
18. Ghoshal K, Majumder S, Li Z, Dong X, Jacob ST. Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation. J Biol Chem 2000;275:539-547 (Pubitemid 30039016)
19. Majumder S, Ghoshal K, Li Z, Bo Y, Jacob ST. Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation. Oncogene 1999;18:6287-6295
20. Motiwala T, Kutay H, Ghoshal K, et al. Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci US A 2004;101:13844-13849 (Pubitemid 39298495)
21. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci US A 1996;93:9821-9826
22. Bachman KE, Herman JG, Corn PG, et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res 1999;59:798-802. (Pubitemid 29086729)
23. Liu Z, Liu S, Xie Z, et al. Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LCMS/MS method. Nucleic Acids Res 2007;35:e31. (Pubitemid 46592893)
24. Majumder S, Ghoshal K, Datta J, et al. Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma. J Biol Chem 2002;277:16048-16058
25. McKim JMJ, Wilga PC, Prezenzer JF, Petrella DK. A biochemical approach to in vitro toxicity testing. Pharm Discov 2005.
26. Chen SM, Leupin W, Rance M, Chazin WJ. Two-dimensional NMR studies of d(GGTTAATGCGGT). (ACCGCATTAACC) complexed with the minor groove binding drug SN-6999. Biochemistry 1992;31:4406-4413
27. Adams A, Leong C, Denny WA, Guss JM. Structures of two minor-groove-binding quinolinium quaternary salts complexed with d(CGCGAATTCGCG)(2) at 1.6 and 1.8 Angstrom resolution. Acta Crystallogr D Biol Crystallogr 2005;61:1348-1353
28. Denny WA, Atwell GJ, Baguley BC, Cain BF. Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles. J Med Chem 1979;22:134-150
29. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005;74:481-514. (Pubitemid 40995515)
30. Datta J, Ghoshal K, Sharma SM, Tajima S, Jacob ST. Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1. J Cell Biochem 2003;88:855-864 (Pubitemid 36337030)
31. Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002;21:5483-5495
32. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-107 (Pubitemid 29036293)
33. McGarvey KM, Fahrner JA, Greene E, et al. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 2006;66:3541-3549
34. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004;142:231-255
35. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007;16 Spec No 1:R50-9. (Pubitemid 47241842)
36. Datta J, Kutay H, Nasser MW, et al. Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008;68:5049-5058
37. Motiwala T, Majumder S, Kutay H, et al. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. Clin Cancer Res 2007;13:3174-3181 (Pubitemid 46944899)
38. Palii SS, Robertson KD. Epigenetic control of tumor suppression. Crit Rev Eukaryot Gene Expr 2007;17:295-316. (Pubitemid 47018213)
39. Brueckner B, Lyko F. DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy. Trends Pharmacol Sci 2004;25:551-554 (Pubitemid 39371143)
40. Ghoshal K, Datta J, Majumder S, et al. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol 2002;22:8302-8319 (Pubitemid 35304062)
41. Kantarjian H, Oki Y, Garcia-Manero G, et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 2007;109:52-57 (Pubitemid 46053042)
42. Fang MZ, Wang Y, Ai N, et al. Tea polyphenol (-)-epigallocatechin-3- gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003;63:7563-7570 (Pubitemid 37466673)
43. Stresemann C, Brueckner B, Musch T, Stopper H, Lyko F. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res 2006;66:2794-2800
44. Villar-Garea A, Fraga MF, Espada J, Esteller M. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 2003;63:4984-4989 (Pubitemid 37022635)
45. Nieto M, Samper E, Fraga MF, et al. The absence of p53 is critical for the induction of apoptosis by 5-aza-2′-deoxycytidine. Oncogene 2004;23:735-743 (Pubitemid 38241274)
46. Pina IC, Gautschi JT, Wang GY, et al. Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase. J Org Chem 2003;68:3866-3873 (Pubitemid 36576636)
47. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000;9:2395-2402
48. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683-692 (Pubitemid 46273572)
49. Garber K. HDAC inhibitors overcome first hurdle. Nat Biotechnol 2007;25:17-19 (Pubitemid 46087886)